Skip to main content

Welcome to a Grasp lesson

Create a free account to keep studying and create your own study path.

Lesson 10

Psychotherapy and Medication for Co-Occurring Conditions: Roles, Evidence, and Limitations

Recommended resources

Welcome to the care module. Earlier in the course, you considered what depersonalization and derealization feel like, why the sensations are not diagnoses on their own, and how anxiety or other factors can accompany them. This lesson turns to treatment: what psychotherapy may help with, when medication may have a role, and why neither should be described as a guaranteed cure. The next lessons will move from treatment evidence to optional coping approaches.

Allow about 35–40 minutes, including the short video segments and readings.


Two related, but different, treatment targets

Imagine someone who feels detached from their surroundings and also has frequent panic attacks. Care could address the panic attacks, the frightening interpretation of the detached feeling, or both. Those are related targets, but success with one does not automatically mean success with the other.

This distinction matters when you hear that a treatment “helps depersonalization.” It could mean that a person feels less anxious while still having some detachment, that episodes become less disruptive, or that the detachment itself becomes less frequent. A clinician would also consider whether the sensations occur alongside depression, substance effects, sleep disruption, or another condition before deciding what to treat.

The following excerpts show how one clinician describes those choices. Treat them as an account of clinical practice, not as proof that each approach works for everyone.

Doctor Explains: How We Treat Depersonalization and Derealization

Watch selected portions of “Doctor Explains: How We Treat Depersonalization and Derealization” by Melissa Shepard, MD, to hear how a clinician distinguishes care for co-occurring conditions from care directed at the detachment itself.

In co-occurring conditions, notice why the clinician assesses anxiety, depression, and substance use. Skip ahead to CBT approaches for her description of addressing distressing interpretations. Finally, watch medication decisions, paying particular attention to her acknowledgment that extensive studies are lacking. Her confidence about particular approaches reflects clinical experience; the research limitations below remain important.

Treating a co-occurring condition is worthwhile in its own right. If panic becomes less frequent, a person may find the detached feeling less frightening or less persistent. That is a possibility, not a promise that treating panic—or depression—will make depersonalization or derealization disappear.



What psychotherapy can offer

Psychotherapy provides a setting to work with both the experience of detachment and the distress around it. In a cognitive behavioral approach, a therapist might help someone examine an interpretation such as “This feeling means I’m permanently losing touch with reality.” The point is not to argue that the feeling is imaginary. The feeling can be vivid and upsetting while the conclusion drawn from it remains open to examination.

The behavioral part may involve returning, at a manageable pace, to ordinary tasks that have become difficult or avoided. If someone repeatedly interrupts a conversation to check whether they “feel real yet,” therapy might address that checking alongside the fear driving it. Progress need not be measured only by whether the sensation vanishes; being able to participate in the conversation with less distress may also matter.

Read the Merck Manual’s treatment section for a wider view of the psychotherapy options and the distinction between those options and medication.

Depersonalization/Derealization Disorder - Psychiatry - Merck Manual Professional Edition

Read the treatment section of the Merck Manual Professional Edition to see the roles it describes for cognitive, behavioral, grounding, and other therapeutic approaches, followed by its caution about medication evidence.

Find “Treatment of Depersonalization/Derealization Disorder.” Read the treatment discussion, stopping before “Prognosis for Depersonalization/Derealization Disorder.” Focus on the difference between a technique’s purpose and evidence that it reliably produces a particular result.

The techniques in that section do not all do the same job. Cognitive work may address fearful interpretations and repetitive thoughts; behavioral work may support engagement with daily life. Grounding draws attention to present surroundings and is sometimes used within therapy. Other approaches may explore difficult feelings or experiences when those are relevant. No history of trauma needs to be presumed for psychotherapy to be considered.

The manual says various psychotherapies help some patients. That is a useful clinical observation, but it is not the same as showing, in large controlled trials, which therapy works best, for whom, and by how much. In particular, a plausible explanation of how CBT might help should not be mistaken for a guarantee that CBT will end the sensations.



What the treatment studies can—and cannot—tell us

A research review can test a clinical claim against studies that compare treatments with a control condition. It can also reveal where studies are missing. The review below is a snapshot of the trials available to its authors, not a complete account of all research that might be published later.

Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD)

Read the “Discussion” and “Conclusion” of this systematic review to distinguish a treatment that has produced inconsistent trial results from an approach that was not adequately tested in the included trials.

In “Discussion,” begin with the paragraph opening the trial summary and stop after its discussion of the biofeedback results; the next paragraph turns to risk-of-bias ratings. Then go to “Conclusion” and read the conclusion. Note both the number of included trials and which interventions they actually studied.

The review found four controlled trials, involving 180 participants in total, each lasting 12 weeks or less. Two lamotrigine trials had conflicting results. A fluoxetine trial did not establish it as an effective treatment for depersonalization itself, although participants with co-occurring anxiety or depression tended to respond better on some measures. The psychotherapy trial tested biofeedback, not CBT: it found an improvement on a measure of momentary symptoms, but not on a measure of more enduring symptoms.

These details support several careful distinctions:

  • Inconsistent results are not an established benefit. The differing lamotrigine findings do not justify calling it a proven treatment.
  • A signal in a subgroup is not a guaranteed effect. Improvement among people who also had anxiety or depression does not show that fluoxetine directly treats depersonalization for everyone.
  • Not tested in these trials is not the same as tested and found ineffective. This review’s psychotherapy trial was biofeedback. It cannot settle whether CBT helps, or how CBT compares with other therapies.

The studies were few, short, and varied in what they tested. That limits confident claims about lasting benefit or about which person might respond. It does not mean that seeking treatment is pointless. It means that treatment decisions should combine the available evidence with a professional assessment of the person’s symptoms, other conditions, preferences, and response over time.



Where medication fits

Medication is often most straightforward to understand when there is a co-occurring condition to treat, such as an anxiety or depressive disorder. A clinician may recommend medication for that condition after considering its likely benefits, risks, and alternatives. If detachment also eases, that is welcome—but it should not be presented in advance as a certain or direct medication effect on depersonalization or derealization.

Medications have also been tried with the detachment symptoms themselves in mind. As the Merck Manual notes, however, none has clearly demonstrable efficacy specifically for depersonalization/derealization disorder. “Not clearly demonstrated” leaves room for individual benefit and further research; it does not support a promise of a cure. Nor do a clinician’s positive experiences with selected patients replace controlled evidence.

For a fictional person with persistent detachment and significant depression, a reasonable treatment discussion might therefore cover psychotherapy, care for the depression, and how to judge whether either is helping. For a person without a co-occurring condition, the rationale for medication may be less clear. In either case, prescribing and changes to prescribed medication belong in a conversation with a qualified clinician, not in an attempt to follow an online treatment story.



Keeping expectations useful

A treatment need not eliminate every sensation immediately to be meaningful. Less fear, fewer interruptions to daily activities, improved sleep or mood, and greater ability to tolerate an episode may all be useful outcomes to discuss with a professional. Equally, a treatment that is not helping—or is causing unwanted effects—deserves review rather than automatic continuation.

The central comparison is this: psychotherapy can work on interpretations, distress, avoidance, and daily functioning; medication may be appropriate for co-occurring conditions, while evidence for medication directed specifically at depersonalization or derealization remains limited. Neither route guarantees recovery, and neither should be dismissed solely because the research is incomplete.

In the next lesson, you will consider a brief, optional grounding approach. Like other coping tools, it can be used to support comfort in the moment without being treated as a substitute for assessment or care.